MongoDB (MDB) Soars After Topping Q1 Views, Analysts Positive but Cautious as Long-Term Competitive Concerns Remain

MongoDB (MDB) PT Lowered to $300 at UBS

UBS analyst Karl Keirstead lowered the price target on MongoDB (NASDAQ: MDB) to $300.00 (from $325.00) while maintaining a Neutral rating.

UPDATE: MongoDB (MDB) PT Raised to $300 at Mizuho Securities

(Updated - June 4, 2021 6:52 AM EDT)

Mizuho Securities analyst Matthew Broome raised the price target on MongoDB (NASDAQ: MDB) to $300.00 (from $265.00) while maintaining a Neutral rating.

The analyst commented, "MDB had a positive start to the year, with upside to revenue,... More

MongoDB (MDB) PT Raised to $415 at Needham & Company

Needham & Company analyst Jack Andrews raised the price target on MongoDB (NASDAQ: MDB) to $415.00 (from $409.00) while maintaining a Buy rating.

The analyst commented, "MDB reported strong 1QFY22 results as revenue was well ahead of consensus and the mid-point of guidance for FY22... More

After-Hours Stock Movers 06/03: (SENS) (ASAN) (FIVE) Higher; (PSTH) (PD) (SUMO) Lower (more...)

Today's After-Hours Movers

Senseonics Holdings, Inc. (NYSE: SENS) 35% HIGHER; announced the results of the PROMISE Study evaluating the accuracy and safety of the next generation Eversense CGM System for up to 180 days with reduced calibrations. The data was presented by Satish Garg, MD, Professor of Medicine at the Barbara Davis Center of the University of Colorado, Denver, and the study group Principal Investigator (PI), as an oral presentation at the 14th Annual ATTD Meeting. Results were presented for both the primary sensor and for a secondary... More

MongoDB (MDB) Tops Q1 EPS by 21c, Revenues Beat; Guides

MongoDB (NASDAQ: MDB) reported Q1 EPS of ($0.15), $0.21 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $181.6 million versus the consensus estimate of $170 million.

"MongoDB delivered an excellent start to fiscal 2022, highlighted by 73% growth of Atlas. Five years ago this month we launched... More